Home Canadian DIN search NIVOLUMAB DIN 02566931 OPDIVO SC DIN 02566931
Status: Approved
Holder: BRISTOL-MYERS SQUIBB CANADA
Health Canada record
Active ingredient(s) NIVOLUMAB 120 MG Dosage form Solution Route Subcutaneous Schedule PRESCRIPTION; SCHEDULE D Class Human ATC L01FF01 NIVOLUMAB Original market date Current status date 26-Mar-2026 Source Health Canada DPD
Establishment licence of the holder Bristol-Myers Squibb Canada — licence 100100, currently licensed, last inspection rating C (2026-03-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NIVOLUMAB DIN Product Company Form Strength Status 02446626 OPDIVO BRISTOL-MYERS SQUIBB CANADA Solution NIVOLUMAB 10 MG Marketed 02446634 OPDIVO BRISTOL-MYERS SQUIBB CANADA Solution NIVOLUMAB 10 MG Marketed 02557320 OPDIVO SC BRISTOL-MYERS SQUIBB CANADA Solution NIVOLUMAB 120 MG Marketed 02541416 OPDUALAG BRISTOL-MYERS SQUIBB CANADA Solution NIVOLUMAB 240 MG; RELATLIMAB 80 MG Marketed
Notices of Compliance NOC Date Submission Reason 37198 2026-02-06 Supplement to a New Drug Submission (SNDS) Addition of a new fill volume
Addition of a manufacturing facility for the drug substance
Addition of a manufacturing facility for the drug product
Changes in drug product manufacturing process
Request a quote for OPDIVO SC
How to read a Canadian DIN record